Cardinal Health announced that it has entered into a definitive agreement to acquire Integrated Oncology Network (ION), a physician-led independent community oncology network, for $1.115 billion in cash.
ION includes over 50 practice sites in 10 states representing more than 100 providers with extensive reach into the local communities they serve. And ION supports a complete continuum of care across its member sites including medical oncology, radiation oncology, urology, diagnostic testing and other ancillary services.
The deal builds on Cardinal Health’s commitment to helping community healthcare providers maintain their independence. And as part of the transaction ION practices will become members of Navista, Cardinal Health’s oncology practice alliance, and ION practice management and practice growth services will become part of Navista’s advanced services and technology offering.
ION practices will also gain access to Navista’s advanced analytics capabilities that leverage artificial intelligence as well as deep expertise from Specialty Networks’ PPS Analytics and SoNaR technology solutions to generate actionable clinical and business insights.
ION’s business model and services are flexible and meets member practices where they are. And its support services include revenue cycle management, payor relations, physician recruitment, practice marketing, finance, accounting, human resources and information technology.
When taken together with Navista offerings like its technology platform and value-based care and ancillary services, ION complements and will expand Cardinal Health’s holistic suite of clinical and practice management solutions designed to support independent community oncology practices.
Cardinal Health’s Pharmaceutical and Specialty Solutions unit operates one of the largest pharmaceutical supply chains in the U.S. with strategically located distribution centers that enable fast and efficient delivery anywhere in the country. And through its Specialty business, Cardinal Health provides reliable distribution and advanced technology solutions to community-based practices across the nation.
This deal is subject to the satisfaction of customary closing conditions, including receipt of required regulatory approvals. The transaction is expected to be accretive to non-GAAP earnings per share after one year following close.
KEY QUOTES:
“Driving growth in specialty continues to be a top priority, and we’ve made investments to expand our offerings through both Navista and our acquisition of Specialty Networks. With their proven model providing extensive support of community oncology across the cancer care continuum and healthcare ecosystem, we’re confident Integrated Oncology Network will further accelerate our oncology strategy and enable us to create value for providers and patients.”
-Jason Hollar, CEO, Cardinal Health
“Integrated Oncology Network and Cardinal Health share a mission of helping community oncology practices deliver world-class patient care and a world-class patient experience to patients and families close to home. This partnership will give community practices the tools and technology they need to enhance and grow that mission and make a positive impact on patient outcomes.”
-Barry Tanner, CEO, Integrated Oncology Network
“By joining forces, Integrated Oncology Network and Cardinal Health are making an exciting commitment to community oncology and, most importantly, to the patients we serve across the country. By joining Navista, cCARE can access the advanced services and technology we need to remain focused on providing high-quality, lower-cost patient-centered cancer care while staying independent—for the good of our patients, our practices and our communities.”
-Jedidiah Monson, MD, founding partner and president of ION member practice California Cancer Associates for Research & Excellence (cCARE)
